Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Leukemia, Lymphocytic, Chronic, B-Cell 4Myelodysplastic Syndromes 3Leukemia, Myeloid, Acute 3Primary Myelofibrosis 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hodgkin Disease 2Triple Negative Breast Neoplasms 1Solid Tumor 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, B-Cell 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Kidney Neoplasms 1Glioma 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 11Azacitidine 10fludarabine 9Whole-Body Irradiation 9Specimen Handling 9Biopsy 9Stem Cell Transplantation 8Mycophenolic Acid 8venetoclax 7fludarabine phosphate 7Tacrolimus 6Cytarabine 6X-Rays 5Hematopoietic Stem Cell Transplantation 5Decitabine 4Cyclosporine 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Magnetic Resonance Spectroscopy 3Injections 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Cyclosporins 3Busulfan 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3ruxolitinib 2pegylated granulocyte colony-stimulating factor 2olutasidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Myelomonocytic, Chronic × Blood Component Removal × Clear all
NCT06928662 2026-05-15

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
36 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡